From the Journals

Vitamin D may protect against COVID-19, especially in Black patients


 

Try upping vitamin D levels to 40 ng/mL or greater to prevent COVID?

In their discussion, the authors noted that significant association of vitamin D levels with COVID-19 risk in Blacks but not in Whites, “could reflect their higher COVID-19 risk, to which socioeconomic factors and structural inequities clearly contribute.

“Biological susceptibility to vitamin D deficiency may also be less frequent in White than Black individuals, since lighter skin increases vitamin D production in response to sunlight, and vitamin D binding proteins may vary by race and affect vitamin D bioavailability.”

Given less than 10% of U.S. adults have a vitamin D level greater than 40 ng/mL, the study findings increase the urgency to consider whether increased sun exposure or supplementation could reduce COVID-19 risk, according to the authors.

“When increased sun exposure is impractical, achieving vitamin D levels of 40 ng/mL or greater typically requires greater supplementation than currently recommended for most individuals of 600-800 IU/d vitamin D3,” they added.

However, Dr. Meltzer also acknowledged that “this is an observational study. We can see that there’s an association between vitamin D levels and likelihood of a COVID-19 diagnosis, but we don’t know exactly why that is, or whether these results are due to the vitamin D directly or other related biological factors.”

All in all, the authors suggested that randomized clinical trials are needed to understand if vitamin D can reduce COVID-19 risk, and as such they should include doses of supplements likely to increase vitamin D to at least 40 ng/mL, and perhaps even higher, although they pointed out that the latter must be achieved safely.

“Studies should also consider the role of vitamin D testing, loading doses, dose adjustments for individuals who are obese or overweight, risks for hypercalcemia, and strategies to monitor for and mitigate hypercalcemia, and that non-White populations, such as Black individuals, may have greater needs for supplementation,” they outlined.

They are now recruiting participants for two separate clinical trials testing the efficacy of vitamin D supplements for preventing COVID-19.

The authors disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
MDedge Rheumatology
First pill for COVID-19 could be ready by year’s end
MDedge Rheumatology
We’re all vaccinated: Can we go back to the office (unmasked) now?
MDedge Rheumatology
Some with long COVID see relief after vaccination
MDedge Rheumatology
High obesity rates in Southern states magnify COVID threats
MDedge Rheumatology
How to talk to patients reluctant to get a COVID-19 vaccine
MDedge Rheumatology
Update: U.S. regulators question AstraZeneca vaccine trial data
MDedge Rheumatology
COVID-19’s impact on lupus inpatients examined in study
MDedge Rheumatology
Less sleep, more burnout linked to higher COVID-19 risk, study shows
MDedge Rheumatology
COVID-19 variants now detected in more animals, may find hosts in mice
MDedge Rheumatology